Search Results - "Sanli, Ulus"

Lenvatinib plus Pembrolizumab for Advanced Endometrial Cancer by Makker, Vicky, Colombo, Nicoletta, Casado Herráez, Antonio, Santin, Alessandro D, Colomba, Emeline, Miller, David S, Fujiwara, Keiichi, Pignata, Sandro, Baron-Hay, Sally, Ray-Coquard, Isabelle, Shapira-Frommer, Ronnie, Ushijima, Kimio, Sakata, Jun, Yonemori, Kan, Kim, Yong Man, Guerra, Eva M, Sanli, Ulus A, McCormack, Mary M, Smith, Alan D, Keefe, Stephen, Bird, Steven, Dutta, Lea, Orlowski, Robert J, Lorusso, Domenica

“…Women with advanced endometrial cancer that progressed during platinum-containing therapy were randomly assigned to lenvatinib plus pembrolizumab or…”
Get full text

Lenvatinib Plus Pembrolizumab in Previously Treated Advanced Endometrial Cancer: Updated Efficacy and Safety From the Randomized Phase III Study 309/KEYNOTE-775 by Makker, Vicky, Colombo, Nicoletta, Casado Herráez, Antonio, Monk, Bradley J, Mackay, Helen, Santin, Alessandro D, Miller, David S, Moore, Richard G, Baron-Hay, Sally, Ray-Coquard, Isabelle, Ushijima, Kimio, Yonemori, Kan, Kim, Yong Man, Guerra Alia, Eva M, Sanli, Ulus A, Bird, Steven, Orlowski, Robert, McKenzie, Jodi, Okpara, Chinyere, Barresi, Gianmaria, Lorusso, Domenica

“…JCO We report the final prespecified analysis for overall survival (OS), along with updated progression-free survival (PFS) and objective response rate (ORR),…”
Get full text

Adjuvant chemotherapy may contribute to an increased risk for metabolic syndrome in patients with breast cancer by Bicakli, Derya Hopanci, Varol, Umut, Degirmenci, Mustafa, Tunali, Didem, Cakar, Burcu, Durusoy, Raika, Karaca, Burcak, Ali Sanli, Ulus, Uslu, Ruchan

“…Purpose Cytotoxic treatment may cause weight gain and important alterations in the metabolic status of breast cancer (BC) patients. The aim of this study was…”
Get full text

Ovarian sertoli-leydig cell tumors: A multicenter long-term clinicopathological analysis of 27 patients by Akman, Levent, Ertas, Ibrahim, Gokcu, Mehmet, Terek, Mustafa, Sanci, Muzaffer, Sanli, Ulus, Zekioglu, Osman, Ozsaran, Ahmet

“…Aim: Information on the clinical behavior of ovarian Sertoli-Leydig cell tumors (SLCTs) as well as its prognostic factors and optimal management is limited due…”
Get full text

Combination of zoledronic acid and serine/threonine phosphatase inhibitors induces synergistic cytotoxicity and apoptosis in human breast cancer cells via inhibition of PI3K/Akt pathway by Surmeli, Zeki, Gursoy, Pinar, Erdogan, Atike Pinar, Bozkurt, Emir, Atmaca, Harika, Uzunoglu, Selim, Sezgin, Canfeza, Şanlı, Ulus Ali, Uslu, Ruchan, Karaca, Burcak

“…The aim of this study was to investigate the cytotoxic and apoptotic effects of zoledronic acid (ZA) in combination with serine/threonine protein phosphatase…”
Get full text

Algorithms for scheduling of chemotherapy plans by Sevinc, Suleyman, Sanli, Ulus Ali, Goker, Erdem

“…Abstract Chemotherapy is used to control and cure cancer by using drugs to destroy cancer cells. Treatment schedules for chemotherapy may vary depending on the…”
Get full text

Enhancement of docetaxel-induced cytotoxicity and apoptosis by all-trans retinoic acid (ATRA) through downregulation of survivin (BIRC5), MCL-1 and LTbeta-R in hormone- and drug resistant prostate cancer cell line, DU-145 by Kucukzeybek, Yuksel, Gul, Mustafa K, Cengiz, Ercument, Erten, Cigdem, Karaca, Burcak, Gorumlu, Gurbuz, Atmaca, Harika, Uzunoglu, Selim, Karabulut, Bulent, Sanli, Ulus A, Uslu, Ruchan

“…The management of hormone-refractory prostate cancer (HRPC) still remains as an important challenge of daily oncology practice. Docetaxel has proved to be a…”
Get full text

Combined gossypol and zoledronic acid treatment results in synergistic induction of cell death and regulates angiogenic molecules in ovarian cancer cells by Atmaca, Harika, Gorumlu, Gurbuz, Karaca, Burcak, Degirmenci, Mustafa, Tunali, Didem, Cirak, Yalcin, Purcu, Duygu Unuvar, Uzunoglu, Selim, Karabulut, Bulent, Sanli, Ulus A, Uslu, Ruchan

“…In the present study, we aimed to evaluate the possible synergistic, cytotoxic effects of combination treatment of gossypol and zoledronic acid, in human…”
Get more information

Overcoming drug resistance in hormone- and drug-refractory prostate cancer cell line, PC-3 by docetaxel and gossypol combination by Cengiz, Ercument, Karaca, Burcak, Kucukzeybek, Yuksel, Gorumlu, Gurbuz, Gul, Mustafa K., Erten, Cigdem, Atmaca, Harika, Uzunoglu, Selim, Karabulut, Bulent, Sanli, Ulus A., Uslu, Ruchan

“…Drug resistance is a significant challenge of daily oncology practice. Docetaxel and gossypol both have antitumoral activity in hormone-refractory prostate…”
Get full text

Regulation of growth factors in hormone‐ and drug‐resistant prostate cancer cells by synergistic combination of docetaxel and octreotide by Erten, Cigdem, Karaca, Burcak, Kucukzeybek, Yuksel, Gorumlu, Gurbuz, Cengiz, Ercument, Gul, Mustafa K., Atmaca, Harika, Uzunoglu, Selim, Karabulut, Bulent, Sanli, Ulus A., Uslu, Ruchan

“…OBJECTIVE To evaluate the effects of combined treatment with docetaxel and octreotide, a somatostatin analogue, on human hormone‐ and drug‐refractory prostate…”
Get full text

Safety and efficacy of regorafenib in patients with treatment-refractory metastatic colorectal cancer in Turkey: the single-arm, open-label REGARD study by Dane, Faysal, Ozgurdal, Kirhan, Yalçın, Şuayib, Benekli, Mustafa, Aykan, Nuri Faruk, Yücel, İdris, Özkan, Metin, Evrensel, Turkkan, Sevinç, Alper, Coskun, Hasan Şenol, Sanli, Ulus Ali, Kara, Ismail Oguz, Yumuk, Perran Fulden

“…ObjectivesRegorafenib improved overall survival in patients with metastatic colorectal cancer (mCRC) refractory to standard therapies in two randomised, phase…”
Get full text

The retrospective analysis of patients with uterine sarcomas: A single-center experience by Terek, Mustafa, Akman, Levent, Hursitoglu, Behiye, Sanli, Ulus, Ozsaran, Zeynep, Tekindal, Mustafa, Dikmen, Yilmaz, Zekioglu, Osman, Ozsaran, Ahmet

“…Background: Uterine sarcomas are rare, malignant, gynecological tumors and show diverse histopathological features. Therefore, there is no consensus on risk…”
Get full text

Profiling of angiogenic cytokines produced by hormone- and drug-refractory prostate cancer cell lines, PC-3 and DU-145 before and after treatment with gossypol by Karaca, Burcak, Kucukzeybek, Yuksel, Gorumlu, Gurbuz, Erten, Cigdem, Gul, Mustafa K, Cengiz, Ercument, Atmaca, Harika, Uzunoglu, Selim, Sanli, Ulus A, Karabulut, Bulent, Uslu, Ruchan

“…In this study, we aimed to investigate the angiogenic cytokine profiles of hormone- and drug-refractory prostate carcinoma cell lines, PC-3 and DU-145. We also…”
Get more information

Gemcitabine treatment in patients with inoperable locally advanced/metastatic pancreatic cancer and prognostic factors by Sezgin, Canfeza, Karabulut, Bulent, Uslu, Ruchan, Sanli, Ulus A., Goksel, Gamze, Yuzer, Yildiray, Goker, Erdem

“…Objective. Most patients with pancreatic cancer show an inoperable locally advanced/ metastatic tumour at the time of diagnosis. The present study was aimed at…”
Get full text

Arsenic Trioxide-mediated Cytotoxicity and Apoptosis in Prostate and Ovarian Carcinoma Cell Lines by USLU, Ruchan, SANLI, Ulus Ali, SEZGIN, Canfeza, KARABULUT, Bulent, TERZIOGLU, Ender, OMAY, Serdar Bedii, GOKER, Erdem

“…We studied the effect of arsenic trioxide (As 2 O 3 ) on prostate and ovarian carcinoma cell lines. As 2 O 3 has been shown to be effective in leukemia, and…”
Get full text

PURE vs. mixed clear cell ovarian carcinomas: Is there any impact on survival? by Güzel, Duygu, Terek, Coşan, Besler, Ayşegül, Serin, Gürdeniz, Önal, Züleyha, Akman, Levent, Göker, Erdem, Ali Şanli, Ulus, Zekioğlu, Osman, Özdemir, Necmettin, Özsaran, Aydın, Yildirim, Nuri

“…•Clear-cell ovarian cancer (CCOC) is a rare type of epithelial ovarian cancer.•Up to now, there have been no clinical data about the importance of clear cell…”
Get full text

Secondary osteosarcoma arising in fibrous dysplasia, case report by Doganavsargil, Basak, Argin, Mehmet, Kececi, Burcin, Sezak, Murat, Sanli, Ulus Ali, Oztop, Fikri

“…Malignant transformation of fibrous dysplasia is very rare. The frequency is increased in polyostotic forms, in McCune–Albright and Mazabraud’s syndromes and…”
Get full text

Efficacy of local ablative therapies in patients with solid tumors treated with immune checkpoint inhibitors and oligoprogression: a single-center analysis by Ozluk, Ahmet Anil, Karateke, Murat, Sanli, Ulus Ali, Karaca, Burcak

“…The concept of oligoprogression reflects a situation where a limited number of metastatic tumor sites have progressed and other metastatic sites are under…”
Get full text

Single-Agent Irinotecan for Recurrent/Metastatic Colorectal Cancer: A Retrospective Analysis by Sanli, Ulus A., Karabulut, Bulent, Uslu, Ruchan, Korkut, Mustafa, Goker, Erdem

“…Objective: To evaluate the efficacy, toxicity and factors affecting the survival rate of patients treated with irinotecan. Subjects and Methods: Data from the…”
Get full text

Preoperative radiotherapy with concomitant chemotherapy in extremity soft tissue sarcomas: long-term results of a single center by Yilmaz, Ugur, Kamer, Serra, Kaya, Huseyin, Sabah, Dundar, Sanli, Ulus Ali, Tamsel, Ipek, Yaman, Banu, Akalin, Taner, Anacak, Yavuz

“…Purpose To assess oncological outcomes of patients receiving neoadjuvant radiochemotherapy (RCT) for soft tissue sarcoma (STS) of the extremities. Methods…”
Get full text